1 Nakae J, "The forkhead transcription factor Foxo1 regulates adipocyte differentiation" 4 : 119-129, 2003
2 Lai CS, "Suppression of adipogenesis and obesity in high-fat induced mouse model by hydroxylated polymethoxyflavones" 61 : 10320-10328, 2013
3 Tontonoz P, "Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activatedtranscription factor" 79 : 1147-1156, 1994
4 Picard F, "Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-c" 429 : 771-776, 2004
5 Li MF, "Rise and fall of anti-obesity drugs" 2 : 19-23, 2011
6 Hardie DG, "Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase" 1123 : 231-238, 1992
7 Cao Z, "Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells" 5 : 1538-1552, 1991
8 Rayalam S, "Phytochemicals and regulation of the adipocyte life cycle" 19 : 717-726, 2008
9 Misra A, "Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: Role of dietary fats and oils" 29 (29): 289S-301S, 2010
10 Liu TF, "Deacetylation by SIRT1 reprograms inflammation and cancer" 4 : 135-147, 2013
1 Nakae J, "The forkhead transcription factor Foxo1 regulates adipocyte differentiation" 4 : 119-129, 2003
2 Lai CS, "Suppression of adipogenesis and obesity in high-fat induced mouse model by hydroxylated polymethoxyflavones" 61 : 10320-10328, 2013
3 Tontonoz P, "Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activatedtranscription factor" 79 : 1147-1156, 1994
4 Picard F, "Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-c" 429 : 771-776, 2004
5 Li MF, "Rise and fall of anti-obesity drugs" 2 : 19-23, 2011
6 Hardie DG, "Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase" 1123 : 231-238, 1992
7 Cao Z, "Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells" 5 : 1538-1552, 1991
8 Rayalam S, "Phytochemicals and regulation of the adipocyte life cycle" 19 : 717-726, 2008
9 Misra A, "Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: Role of dietary fats and oils" 29 (29): 289S-301S, 2010
10 Liu TF, "Deacetylation by SIRT1 reprograms inflammation and cancer" 4 : 135-147, 2013
11 Li S, "Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones" 1 : 2-12, 2009
12 Lai CS, "Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet-induced obesity via activation of AMPK signaling" 59 : 1883-1895, 2015
13 Jin Q, "C/EBPa regulates SIRT1 expression during adipogenesis" 20 : 470-479, 2010
14 Guilherme A, "Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes" 9 : 367-377, 2008
15 Pan MH, "5-Hydroxy-3,6,7,8,30,40-hexamethoxyflavone induces apoptosis through reactive oxygen species production, growth arrest and DNA damage-inducible gene 153 expression, and caspase activation in human leukemia cells" 55 : 5081-5091, 2007